SEC Company Response from Vaxcyte, Inc. (PCVX) (CIK 0001649094) (PCVX) — Jun 9, 2020
Vaxcyte, Inc. (PCVX) (CIK 0001649094)
Date: June 9, 2020 · CIK: 0001649094 · Accession: 0001193125-20-164572
AI Filing Summary & Sentiment
File numbers found in text: 333-238630
Letter
BofA Securities, Inc.
One Bryant Park
New York, New York 10036
Jefferies LLC
520 Madison Avenue
New York, New York 10022
Evercore Group L.L.C.
55 East 52nd Street
New York, New York 10055
June 9, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Ada D. Sarmento
Mary Beth Breslin
Michael Fay
Al Pavot
Re: Vaxcyte, Inc.
Registration Statement on Form S-1
File No. 333-238630
Acceleration Request
Requested Date: Thursday, June 11, 2020
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Vaxcyte, Inc. (the “Company”) for acceleration of the effective date of the above-referenced Registration Statement, requesting effectiveness as of 4:00 P.M., Eastern Time, on June 11, 2020, or at such later time as the Company or its outside counsel, Cooley LLP, may request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.
Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the securities, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Signature Page Follows]
Very truly yours,
BOFA SECURITIES, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP BofA Securities, Inc. One Bryant Park New York, New York 10036 Jefferies LLC 520 Madison Avenue New York, New York 10022 Evercore Group L.L.C. 55 East 52nd Street New York, New York 10055 June 9, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ada D. Sarmento Mary Beth Breslin Michael Fay Al Pavot Re: Vaxcyte, Inc. Registration Statement on Form S-1 File No. 333-238630 Acceleration Request Requested Date: Thursday, June 11, 2020 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Vaxcyte, Inc. (the “Company”) for acceleration of the effective date of the above-referenced Registration Statement, requesting effectiveness as of 4:00 P.M., Eastern Time, on June 11, 2020, or at such later time as the Company or its outside counsel, Cooley LLP, may request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the securities, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [Signature Page Follows] Very truly yours, BOFA SECURITIES, INC. By: /s/ Michael Liloia Authorized Signatory JEFFERIES LLC By: /s/ Michael Brinkman Authorized Signatory EVERCORE GROUP L.L.C. By: /s/ Gloria Tang Authorized Signatory [Signature Page to Underwriters’ Acceleration Request]